lorvotuzumab
specific
heterophile antibody
gamma globulin
heterophil antibody
Forssman antibody
reagin
antipolyvalent
immunocytic
multiantigenic
antigenically
cibisatamab
cytotropic antibody
antiphospholipid antibody
antimonoclonal
hemagglutination
anaphylactic antibody
cytophilic antibody
tislelizumab
brolucizumab
guselkumab
immunotolerable
abagovomab
ravulizumab
-zumab
gevokizumab
olaratumab
pidilizumab
hyperimmunoglobulin
immunoprecipitant
radioimmunoelectrophoresis
neoantigen
autoagglutinin
seromic
antigenemia
blood group
immunoglobulinemia
radioimmunoreactivity
allotype
sonepcizumab
tucotuzumab
immunologically
elotuzumab
immunocytometric
idiotope
immunocharacterization
muromonab
amlitelimab